Search results
U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15
Reuters via Yahoo News· 2 years agoThe vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency...
Pfizer's 3-Dose COVID Vaccine Is 80% Effective in Kids Under 5
People via Yahoo News· 2 years agoPfizer and BioNTech are seeking emergency use authorization of its COVID vaccine for kids under 5...
Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and partner BioNTech seek authorization from the FDA for using their bivalent COVID-19...
Vaccine aimed at preventing meningitis in kids approved by FDA. What happens next?
Miami Herald via Yahoo News· 7 months agoA new vaccine from Pfizer has been approved by the Food and Drug Administration as the first shot of...
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full...
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: GSK said Wednesday that its new Arexvy vaccine for respiratory syncytial virus pulled in 709 million pounds, or about $860 million, in its...
Pfizer & BioNTech COVID Jab Booster Effective in Kids Under 5
Zacks via Yahoo Finance· 2 years agoPfizer PFE and its Germany-based partner BioNTech’s BNTX mRNA-based COVID-19 vaccine elicited a...
With COVID vaccines nearing approval for youngest children, Kansas has pre-ordered 66,800 doses
The Topeka Capital-Journal via Yahoo News· 2 years agoKansas public health officials have pre-ordered doses of COVID-19 vaccines for the youngest of...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 week agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...